ストックスクリーナーアプリを入手
30.63
4.65%
1.36
アフターアワーズ：
30.83
0.20
+0.65%
前日終値:
$29.27
開ける：
$30.95
24時間の取引高:
103.30K
Relative Volume:
2.52
時価総額：
$1.48B
収益：
$33.89M
当期純損益:
$-29.52M
株価収益率:
-48.95
EPS:
-0.6257
ネットキャッシュフロー:
$-26.96M
1週間 パフォーマンス:
-6.19%
1か月 パフォーマンス:
+18.72%
6か月 パフォーマンス:
+107.66%
1年 パフォーマンス:
+756.78%
1日の値動き範囲:
$30.52
$33.10
1週間の範囲:
$28.39
$33.10
52週間の値動き範囲:
$2.9855
$41.89
Nanobiotix Adr Stock (NBTX) Company Profile
Compare NBTX vs VRTX, REGN, ALNY, ARGX, INSM
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NBTX
Nanobiotix Adr
|
30.63 | 1.42B | 33.89M | -29.52M | -26.96M | -0.6257 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
Nanobiotix Adr Stock (NBTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-06 | 開始されました | TD Cowen | Buy |
| 2024-08-28 | 開始されました | Guggenheim | Buy |
| 2023-12-08 | 開始されました | Leerink Partners | Outperform |
| 2021-01-06 | 開始されました | Evercore ISI | Outperform |
Nanobiotix Adr (NBTX) 最新ニュース
Cancer Drug Developer Nanobiotix Denies Any Active Takeover Process - Benzinga
Nanobiotix (NASDAQ:NBTX) Shares Gap UpShould You Buy? - MarketBeat
El Pollo Loco Posts Upbeat Q4 Results, Joins Kyivstar Group, American Public Education And Other Big Stocks Moving Higher On Friday - Benzinga
NBTX Forecast, Price Target & Analyst Ratings | NANOBIOTIX SAADR (NASDAQ:NBTX) - ChartMill
Nanobiotix (NASDAQ:NBTX) Shares Gap DownWhat's Next? - MarketBeat
Nanobiotix S.A.Sponsored ADR (NASDAQ:NBTX) Short Interest Down 75.8% in February - MarketBeat
Nanobiotix (NASDAQ:NBTX) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
Nanobiotix (NASDAQ:NBTX) Hits New 1-Year HighShould You Buy? - MarketBeat
Nanobiotix (NASDAQ:NBTX) Sees Strong Trading VolumeShould You Buy? - MarketBeat
Nanobiotix (NASDAQ:NBTX) Sets New 52-Week HighWhat's Next? - MarketBeat
Short Interest in Nanobiotix S.A.Sponsored ADR (NASDAQ:NBTX) Grows By 114.9% - MarketBeat
NANOBIOTIX to Participate in Investor Conferences in March - ChartMill
Nanobiotix (NASDAQ:NBTX) Sees Large Volume IncreaseHere's What Happened - MarketBeat
Nanobiotix (NASDAQ:NBTX) Shares Gap Up Following Analyst Upgrade - Defense World
Nanobiotix (NASDAQ:NBTX) Shares Gap Up After Analyst Upgrade - MarketBeat
Nanobiotix (NASDAQ:NBTX) Stock Price Up 5.8% – Here’s What Happened - Defense World
Nanobiotix (NASDAQ:NBTX) Shares Up 5.8%Should You Buy? - MarketBeat
Looking Into Nanobiotix SA's Recent Short Interest - Sahm
Nanobiotix (NASDAQ:NBTX) Stock Price Down 6.2%Here's What Happened - MarketBeat
Nanobiotix (NASDAQ:NBTX) Shares Gap Up – Here’s Why - Defense World
Nanobiotix (NASDAQ:NBTX) Trading Up 3.3% – Time to Buy? - Defense World
Nanobiotix (NASDAQ:NBTX) Stock Price Up 3.3%Time to Buy? - MarketBeat
Nanobiotix S.A. – Sponsored ADR (NASDAQ:NBTX) Receives Average Recommendation of “Hold” from Brokerages - Defense World
Nanobiotix (NASDAQ:NBTX) Shares Up 5%What's Next? - MarketBeat
Preferred dividends of Nanobiotix SA Sponsored ADR – LS:A2QKZM - TradingView
Nanobiotix S.A. – Sponsored ADR (NASDAQ:NBTX) Receives $11.00 Consensus Price Target from Analysts - Defense World
Leerink Partnrs Decreases Earnings Estimates for Nanobiotix - Defense World
Semtech Posts Mixed Q3 Results, Joins Zhihu, Nvidia And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Outset Medical, Gemini Space Station, CoreWeave And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Nanobiotix provides update on JNJ-1900 after Johnson & Johnson transfer - MSN
Nanobiotix enters royalty-based financing pact with HealthCare Royalty for $71M - MSN
Nanobiotix (NASDAQ:NBTX) Stock Price Up 10.3%Still a Buy? - MarketBeat
Nanobiotix SA ADR Reports Revenue Surge Amid Strategic Advances - MSN
Nanobiotix Adr (NBTX) 財務データ
収益
当期純利益
現金流量
EPS
1.82%
大文字化:
|
ボリューム (24 時間):